Building strong evidence for an immune health claim is high on the agenda for many in our industry today, so NutraIngredients asked an expert about the process of conducting human clinical trials with this specific aim in mind.
There are over 1,600 human clinical trials on probiotics listed in ClinicalTrials.gov and the WHO’s trial database, according to a new analysis that seeks to address the misconception that there is no human data around probiotics.
As has been reported for other dietary supplement categories, “March was an incredible month” for the omega-3 category, but reports are that those levels have not been maintained through April, said Ellen Schutt, executive director of GOED.
There is increasing pressure for the European Food Safety Authority (EFSA) to echo the policy of its pharmaceutical cousin the European Medicines Agency (EMA) to publish clinical trials from industry dossiers.
Investment for the design and running of clinical trials is a major expense for the industry, but taking shortcuts to reduce the initial investment needed can be very costly in the long-term, according to one expert.
There’s gold to be found in them health claims mountains, but prospectors from the European Food Safety Authority (EFSA) must be happy with the little chunks that add up to a lot, and stop searching for nuggets the size of your fist.
Apparently conflicting results from randomized clinical trials and observational studies abound in the scientific literature. In the third part of a four-part series on antioxidants, NutraIngredients looks to get behind the contradictions.
The traditional scientific model does not always apply to dietary
supplements, nor does the objective of government-funded clinical
trials in testing them necessarily suit their common applications,
according to NutraCon panelists.